Source: ERJ Open Res, 6 (2) 00306-2019; 10.1183/23120541.00306-2019
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
Shohei Hamada, Hidenori Ichiyasu, Megumi Inaba, Hiroshi Takahashi, Tomoki Sadamatsu, Kimitaka Akaike, Aiko Masunaga, Yasumasa Tashiro, Naomi Hirata, Takeshi Yoshinaga, Takuro Sakagami. Prognostic impact of pre-existing interstitial lung disease in non-HIV patients with Pneumocystis pneumonia. ERJ Open Res, 6 (2) 00306-2019; 10.1183/23120541.00306-2019

Member's Comments

No comment yet.

Related content which might interest you: Clinical outcome and prognostic factors of acute respiratory failure due to pneumocystis pneumonia in non-HIV patients Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Clinical prognostic factors for pneumocystis pneumonia in non-HIV patients Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients Source: Eur Respir J 2001; 17: 87-93 Year: 2001 Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer Source: International Congress 2018 – Clinical challenges in respiratory infection Year: 2018 Evaluation of incidental exacerbation of interstitial pneumonia in patients with non-respiratory diseases Source: International Congress 2017 – Rare diseases Year: 2017 Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Role of pneumocystis jiroveci in interstitial lung disease Source: Eur Respir J 2004; 24: Suppl. 48, 557s Year: 2004 Impact of neutrophil function on outcomes of community-acquired pneumonia in patients with cancer Source: Eur Respir Rev 2008; 17: 83-85 Year: 2008 Assessment of the characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Pneumocystis pneumonia in an HIV-negative patient with no overt risk factors on presentation Source: Eur Respir J 2010; 35: 927-929 Year: 2010 The post-tuberculosis lung changes as risk factor of the community-acquired pneumonia delayed course Source: Eur Respir J 2006; 28: Suppl. 50, 351s Year: 2006 Prognostic determinants in IPF patients with the histological features of usual interstitial pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 526s Year: 2001 Clinical features of pulmonary aspergillosis in patients with chronic fibrosing interstitial pneumonia Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Recurrence predictive factors of cryptogenic organizing pneumonia Source: International Congress 2015 – Connective tissue disorders Year: 2015 Difference of the clinical characteristics and outcome between interstitial lung disease with dermatomyositis and idiopathic interstitial pneumonia Source: International Congress 2017 – Lung function testing Year: 2017 Clinical manifestations and a prognostic factor of pneumocystis pneumonia without HIV infection Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies Year: 2011 COPD is associated with increased mortality in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: 346-351 Year: 2006 Prognostic evaluation of COPD patients with pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 257s Year: 2005 Clinicoradiological features of pulmonary tuberculosis associated with interstitial pneumonia Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014